The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Synucleinopathies: Clinical and Pathological Implications
Abstract
The synucleinopathies are a diverse group of neurodegenerative disorders that share a common pathologic lesion composed of aggregates of insoluble alpha-synuclein protein in selectively vulnerable populations of neurons and glia. Growing evidence links the formation of abnormal filamentous aggregates to the onset and progression of clinical symptoms and the degeneration of affected brain regions in neurodegenerative disorders. These disorders may share an enigmatic symmetry, i.e., missense mutations in the gene encoding for the disease protein (alpha-synuclein) cause familial variants of Parkinson disease as well as its hallmark brain lesions, but the same brain lesions also form from the corresponding wild-type brain protein in the more common sporadic varieties of Parkinson disease. It is likely that clarification of this enigmatic symmetry in 1 form of synucleinopathy will have a profound impact on understanding the mechanisms underlying all these disorders. Furthermore, these efforts will likely lead to novel diagnostic and therapeutic strategies in regard to the synucleinopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,641
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
Clayton, D. F., & George, J. M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01213-7 · Cited by 779
Tu, P., Galvin, J. E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. Q., & Lee, V. M. ‐. (1998) · Annals of Neurology · doi:10.1002/ana.410440324 · Cited by 686 · cited 2×
“Significantly, aS has been implicated as a major component of the tubulofilamentous inclusions found in oligodendrocytes in multiple system atrophy known as glial cytoplasmic inclusions (GCIs).(2,3,5,6,28) Multiple system atrophy consists of a syndrome complex with parkinsonism and a combination of cerebellar, autonom…”
BackgroundResultSelf-citationAlpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease
Hurtig, H. I., Trojanowski, J. Q., Galvin, J., Ewbank, D., Schmidt, M. L., Lee, V. M. Y., Clark, C. M., Glosser, G., Stern, M. B., Gollomp, S. M., et al. (2000) · Neurology · doi:10.1212/wnl.54.10.1916 · Cited by 601
Self-citationProspects for new restorative and neuroprotective treatments in Parkinson's disease
Dunnett, S. B., & Björklund, A. (1999) · Nature · doi:10.1038/399a032 · Cited by 537
Lippa, C. F., Fujiwara, H., Mann, D. M. A., Giasson, B., Baba, M., Schmidt, M. L., Nee, L. E., O'Connell, B., Pollen, D. A., St. George-Hyslop, P., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65722-7 · Cited by 533
Self-citationGiasson, B. I., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7619 · Cited by 507
Self-citationSynucleins in synaptic plasticity and neurodegenerative disorders
Clayton, D. F., & George, J. M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991001)58:1<120::aid-jnr12>3.0.co;2-e · Cited by 442
Galvin, J. E., Uryu, K., Lee, V. M.-Y., & Trojanowski, J. Q. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13450 · Cited by 422
Self-citationGenetic Classification of Primary Neurodegenerative Disease
Hardy, J., & Gwinn-Hardy, K. (1998) · Science · doi:10.1126/science.282.5391.1075 · Cited by 343
Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.
Ji, H. W., Liu, Y. E., Jia, T., Wang, M., Liu, J., Xiao, G., Joseph, B. K., Rosen, C. A., & Shi, Y. (1997) · PubMed · Cited by 327
Okazaki, H., Lipkin, L. E., & Aronson, S. M. (1961) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196104000-00007 · Cited by 301
Trojanowski, J. Q., Goedert, M., Iwatsubo, T., & Lee, V. M.-Y. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400432 · Cited by 297
Self-citationAlpha‐synuclein in Lewy Body Disease and Alzheimer's Disease
Hashimoto, M., & Masliah, E. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00552.x · Cited by 254
Non-Aβ Component of Alzheimer's Disease Amyloid (NAC) Revisited
Culvenor, J. G., McLean, C. A., Cutt, S., Campbell, B. C. V., Maher, F., Jäkälä, P., Hartmann, T., Beyreuther, K., Masters, C. L., & Li, Q.-X. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65220-0 · Cited by 180
Identification, localization and characterization of the human γ-synuclein gene
Lavedan, C., Leroy, E., Dehejia, A., Buchholtz, S., Dutra, A., Nussbaum, R. L., & Polymeropoulos, M. H. (1998) · Human Genetics · doi:10.1007/s004390050792 · Cited by 179
Goedert, M. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0466 · Cited by 172
Duda, J. E., Shah, U., Arnold, S. E., Lee, V. M. ‐., & Trojanowski, J. Q. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7228 · Cited by 137
Self-citationZur pathologischen Anatomie der Paralysis agitans
Fünfgeld, E. W. (1923) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02869021 · Cited by 135
Newell, K. L., Boyer, P., Gomez-Tortosa, E., Hobbs, W., Hedley-Whyte, E. T., Vonsattel, J. P., & Hyman, B. T. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199912000-00007 · Cited by 128
Assignment of Human α-Synuclein (SNCA) and β-Synuclein (SNCB) Genes to Chromosomes 4q21 and 5q35
Spillantini, M. G., Divane, A., & Goedert, M. (1995) · Genomics · doi:10.1006/geno.1995.1063 · Cited by 109
Synoretin—A New Protein Belonging to the Synuclein Family
Surguchov, A. P., Surgucheva, I. G., Solessio, E. C., & Baehr, W. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0735 · Cited by 96
Tau and Synuclein and Their Role in Neuropathology
Dickson, D. W. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00548.x · Cited by 88
Pathobiology of the Lewy body.
Je, G., Vm, L., Schmidt, M. L., Ph, T., Iwatsubo, T., & Trojanowski, J. Q. (1999) · PubMed · Cited by 86
Self-citationCloning and Characterization of the cDNA Encoding a Novel Brain‐Specific 14‐kDa Protein
Tobe, T., Nakajo, S., Tanaka, A., Mitoya, A., Omata, K., Nakaya, K., Tomita, M., & Nakamura, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10991.x · Cited by 71
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
“The brains of all of the incidental cases and of individuals with clinically overt sporadic PD display the presence of -synuclein-immunoreactive LNs and LBs while at the same time being free of intracytoplasmic inclusions related to non-PD -synucleinopathies [35,41].”
BackgroundThe new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
Metadata
- Authors
- Galvin, J. E., Lee, V. M.-Y., & Trojanowski, J. Q.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2001-02-01
- Volume
- 58
- Issue
- 2
- Pages
- 186
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2037948191
- Cited by
- 466
- References
- 31
- FWCI
- 20.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.